Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q2 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.